Put Contract Overview: The $260.00 put contract has a bid of $5.20, allowing investors to buy ECL shares at a cost basis of $254.80, which is a 2% discount from the current price of $266.48. There is a 63% chance the contract may expire worthless, potentially yielding a 2.00% return or 11.40% annualized.
Call Contract Overview: The $270.00 call contract has a bid of $6.50, offering a potential total return of 3.76% if the stock is called away at expiration. With a 53% chance of expiring worthless, the premium could provide a 2.44% additional return or 13.90% annualized.
Volatility Insights: The implied volatility for the put contract is 23% and for the call contract is 22%, while the actual trailing twelve-month volatility is calculated at 19%.
Tracking and Resources: Stock Options Channel will monitor and publish the changing odds of both put and call contracts over time on their website, providing additional insights and trading history for investors.
ECL
$259.53+Infinity%1D
Analyst Views on ECL
Wall Street analysts forecast ECL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ECL is 295.82 USD with a low forecast of 248.00 USD and a high forecast of 325.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
21 Analyst Rating
Wall Street analysts forecast ECL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ECL is 295.82 USD with a low forecast of 248.00 USD and a high forecast of 325.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Buy
7 Hold
0 Sell
Moderate Buy
Current: 261.110
Low
248.00
Averages
295.82
High
325.00
Current: 261.110
Low
248.00
Averages
295.82
High
325.00
Evercore ISI
Eric Boyes
In Line -> Outperform
upgrade
$300
2025-11-03
Reason
Evercore ISI
Eric Boyes
Price Target
$300
2025-11-03
upgrade
In Line -> Outperform
Reason
Evercore ISI analyst Eric Boyes upgraded Ecolab to Outperform from In Line with a $300 price target.
Evercore ISI
In Line -> Outperform
upgrade
$265 -> $300
2025-11-03
Reason
Evercore ISI
Price Target
$265 -> $300
2025-11-03
upgrade
In Line -> Outperform
Reason
As previously reported, Evercore ISI upgraded Ecolab to Outperform from In Line with a price target of $300, up from $265. Ecolab is "one of the few businesses in Chemicals with momentum" into 2026, says the analyst, who sees 2026 as the year Ecolab's structural earnings potential becomes more broadly apparent as the Ovivo acquisition closes and Digital monetization scales. The pullback of about 8% after Q3 results on transient softness in Water for paper and industrials offers a better risk-reward, the analyst added.
UBS
Neutral
downgrade
$299 -> $291
2025-10-31
Reason
UBS
Price Target
$299 -> $291
2025-10-31
downgrade
Neutral
Reason
UBS lowered the firm's price target on Ecolab to $291 from $299 and keeps a Neutral rating on the shares.
Stifel
Buy
downgrade
$303 -> $300
2025-10-29
Reason
Stifel
Price Target
$303 -> $300
2025-10-29
downgrade
Buy
Reason
Stifel lowered the firm's price target on Ecolab to $300 from $303 and keeps a Buy rating on the shares. The "main negative" in the quarter was the sequential deceleration in volumes, but management asserted the business does not require stronger volume growth from today's levels to achieve the 12%-15% adjusted EPS growth next year and beyond, the analyst tells investors.
About ECL
Ecolab Inc. is engaged in offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. The Company’s Global Industrial segment provides water treatment and process applications, and cleaning and sanitizing solutions primarily to large industrial customers within the manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. Its Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education and retail industries. Its Global Healthcare & Life Sciences segment provides specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries. Its Global Pest Elimination segment provides services designed to detect, prevent, and eliminate pests, such as rodents and insects.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
